Gresonitamab (AMG 910) is a half-life extended bispecific T-cell engager (BiTE) antibody designed to target CD3-positive T cells and tumor cells expressing CLDN18.2. This antibody facilitates the engagement and activation of T cells at tumor sites, enhancing the immune response against cancer cells. Gresonitamab is primarily utilized in research focused on adenocarcinoma, providing a valuable tool for investigating immune-based therapeutic strategies in this cancer type.
Gresonitamab (AMG 910) is a half-life extended bispecific T-cell engager (BiTE) antibody designed to target CD3-positive T cells and tumor cells expressing CLDN18.2. This antibody facilitates the engagement and activation of T cells at tumor sites, enhancing the immune response against cancer cells. Gresonitamab is primarily utilized in research focused on adenocarcinoma, providing a valuable tool for investigating immune-based therapeutic strategies in this cancer type.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
